[Clinical efficacy of stereotactic radiation therapy combined with temozolomide on recurrent brain glioma]. [electronic resource]
Producer: 20181105Description: 394-397 p. digitalISSN:- 1672-7347
- Antineoplastic Agents, Alkylating -- adverse effects
- Brain Neoplasms -- mortality
- Chemoradiotherapy -- adverse effects
- Combined Modality Therapy
- Dacarbazine -- adverse effects
- Glioma -- mortality
- Humans
- Neoplasm Recurrence, Local -- therapy
- Radiosurgery -- adverse effects
- Retrospective Studies
- Survival Rate
- Temozolomide
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.